Other languages Teva Pharmaceutical Industries Ltd (ADR) Nasdaq

Equities

US8816242098

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

En Direct des Marchés : Renault, Carrefour, Airbus, Sodexo, Ipsen, Elis, Mersen, Blackstone, Tesla...	Jul. 02
Juillet attaque (timidement) dans le vert	Jul. 02
Borsa di Italia: Luglio inizia (timidamente) in verde	Jul. 02
Bolsa de Madrid: Julio comienza (tímidamente) en verde	Jul. 02
Sector Update: Health Care Stocks Retreat Late Afternoon	Jul. 01
Sector Update: Health Care Stocks Slipping in Afternoon Trading	Jul. 01
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01
Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	Jul. 01
Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	Jul. 01
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01
FTC Opens Investigation Into Teva Pharmaceuticals	Jul. 01
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz	Jul. 01
Les nouvelles données portant sur AJOVY® (fremanezumab) dans la prévention de la migraine remettent en question les pauses thérapeutiques	Jun. 28
Neue Daten zu AJOVY® (Fremanezumab) zur Migräneprävention stellen Behandlungspausen in Frage	Jun. 28
Teva Pharmaceutical Industries Ltd Announces New AJOVY® (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	Jun. 28
Le laboratoire Teva solde un litige avec le fisc israélien	Jun. 25
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation	Jun. 25
Teva settles tax dispute in Israel with $750 mln payment	Jun. 25
Teva Pharmaceutical Launches Generic Victoza in US	Jun. 24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 04:41 am EST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 03:19 pm EDT